Oruka Therapeutics (NASDAQ:ORKA – Get Free Report) is one of 39 publicly-traded companies in the “Diagnostic substances” industry, but how does it contrast to its peers? We will compare Oruka ...

Opinions expressed by Forbes Contributors are their own. Steven covers accessibility and assistive technologies. In all my briefings with Apple on AirPods over the years, one of the first things ...

Oruka Therapeutics’ rivals have higher revenue and earnings than Oruka Therapeutics. Oruka Therapeutics is trading at a higher price-to-earnings ratio than its rivals, indicating that it is ...

Stifel has launched its coverage on pre-clinical stage biotech Oruka Therapeutics (NASDAQ:ORKA) with a buy recommendation and ...

H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Oruka Therapeutics (ORKA – Research Report) today and set a price ...

MENLO PARK, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the ...

Earphones that tune out voices but not birdsong; traffic but not emergency sirens. Earplugs that are also hearing aids... A ...

which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

France’s Naval Group has confirmed a deal with the Royal Netherlands Navy to build four Orka-class submarines to replace the ...

Dai Nippon Printing Co., Ltd. +7.53% +34.58% Dai Nippon Printing Co., Ltd. +0.00% +0.00% ...

Comrade Adams Oshiomhole will lead the others involving the State Party Chairman, Emperor Jarret Tenebe and State party ...